Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- PainTEQ, LLC
- Study ID
- NCT07547215
- Status
- Recruiting
Conditions
- Sacroiliac Joint Dysfunction
- Sacroiliac Joint Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bone Allograft — OTHERThe PainTEQ TRAQ™ Posterior SI Joint Implant is processed human bone tissue that has been precision milled from cortical and cancellous bone. The allograft pierces the SI joint cortices and provides a scaffold around which new bone can grow.
Study Details
The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.
Key Dates
- Start date
- May 27, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Composite safety and efficacy endpoint [ Time Frame: Month 6 ]
Central Contacts
- Lalit Venkatesan, PhD18552487246
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pain Institute of Southern Arizona | Tucson | Arizona | 85712 |
Find similar trials in Tucson, AZ
By research site
Related Studies
- Post-Market Clinical Study on a Modular SI Joint Fusion SystemEnrolling By Invitation · CornerLoc · Port Jefferson Station, New York
- Particulate vs. Non-Particulate Steroid for Sacroiliac Joint InjectionPHASE4 · Recruiting · University of New Mexico · Albuquerque, New Mexico
- Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint FusionRecruiting · CornerLoc · Port Charlotte, Florida
- Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1Recruiting · Nevro Corp · Lodi, California